Clinical trial
Study of Pyridoxine for Hand-Foot Syndrome
NCT00446147 · Asan Medical Center, Other · Completed
Key facts
| NCT number | NCT00446147 |
|---|---|
| Title | Study of Pyridoxine for Hand-Foot Syndrome |
| Official title | Double-Blind Phase III Study of Pyridoxine vs Placebo for the Prevention of Capecitabine-induced Hand-Foot Syndrome |
| Lead sponsor | Asan Medical Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hand-foot Syndrome |
| Intervention type | Drug |
| Interventions | Pyridoxine, Placebo |
| Enrollment | 389 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 12, 2007 |
| Last update posted | Feb 25, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: